Analysis of mutations in TP53, APC, K-ras, and DCC genes in the non-dysplastic mucosa of patients with inflammatory bowel disease

International Journal of Colorectal Disease

Volumn 24, Issue 10, 2009, Pages 1141-1148

  Rapozo, Davy Carlos Mendes ^a   Grinmann, Ana Braunstein ^a   Carvalho, Ana Teresa Pugas ^a,c   Souza, Heitor Siffert P ^b   Soares Lima, Sheila Coelho ^a   Almeida Simão, Tatiana ^a   De Paiva, Daurita ^a   Abby, Fálvio ^a   Albano, Rodolpho Mattos ^a   Pinto, Luiz Felipe Ribeiro ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c NONE   (Brazil)

Author keywords

APC; Crohn's disease; K ras; Non dysplastic mucosa; TP53; Ulcerative colitis

Indexed keywords

APC PROTEIN; AZATHIOPRINE; CORTICOSTEROID; CYTOSINE; GENE PRODUCT; K RAS PROTEIN; LEUCINE; MESALAZINE; PROTEIN DCC; PROTEIN P53; SALAZOSULFAPYRIDINE; SERINE; THYMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CLINICAL ARTICLE; CODON; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; CROHN DISEASE; DISEASE COURSE; DNA EXTRACTION; FEMALE; GENE LOSS; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADOLESCENT; ADULT; AGED; BASE SEQUENCE; CODON; COLITIS, ULCERATIVE; CROHN DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; POINT MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTORS, CELL SURFACE; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 69849098545     PISSN: 01791958     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00384-009-0748-5     Document Type: Article

References (46)

1. Eaden JA, Mayberry JF (2000) Colorectal cancer complicating ulcerative colitis: A review. Am J Gastroenterol 95:2710-2719
2. Lakatos L, Mester G, Erdelyi Z, David G, Pandur T, Balogh M et al (2006) Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population-based study. Inflamm Bowel Dis 12:205-211
3. Delaunoit T, Limburg PJ, Goldberg RM, Lymp JF, Loftus EV Jr (2006) Colorectal cancer prognosis among patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 4:335-342
4. Bernstein CN, Blanchard JF, Kliewer E, Wajda A (2001) Cancer risk in patients with inflammatory bowel disease: A population-based study. Cancer 91:854-862
5. Jess T, Loftus EV Jr, Velayos FS, Harmsen WS, Zinsmeister AR, Smyrk TC et al (2006) Risk of intestinal cancer in inflammatory bowel disease: A population-based study from Olmsted county, Minnesota. Gastroenterology 130:1039-1046
6. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228-1233
7. Karlén P, Löfberg R, Broström O, Leijonmarck CE, Hellers G, Persson PG (1999) Increased risk of cancer in ulcerative colitis: A population-based cohort study. Am J Gastroenterol 94:1047-1052
8. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 48:526-535
9. Lewis JD, Deren JJ, Lichtenstein GR (1999) Cancer risk in patients with inflammatory bowel disease. Gastroenterol Clin North Am 28:459-477
10. Levin B (1999) Risk of cancer in ulcerative colitis. Gastrointest Endosc 49:S60-S62
11. Askling J, Dickman PW, Karlén P, Broström O, Lapidus A, Löfberg R, Ekbom A (2001) Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120:1356-1362
12. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451-459
13. Loftus EV Jr, Harewood GC, Loftus CG, Tremaine WJ, Harmsen WS, Zinsmeister AR, Jewell DA, Sandborn WJ (2005) PSC-IBD: A unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut 54:91-96
14. Mattar R, Alexandrino AM, Laudanna AA (1999) Infrequent p53 gene alterations in ulcerative colitis. Braz J Med Biol Res 32:1083-1088
15. Davies RJ, Miller R, Coleman N (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nature 5:199-209
16. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GE et al (1993) Prognostic value of p53 overexpression and K-ras gene mutations in colorectal cancer. Gastroenterology 104:57-64
17. Shivapurkar N, Huang L, Ruggeri B, Swalsky PA, Bakker A, Finkelstein S et al (1997) K-ras and p53 mutations in aberrant crypt foci and colonic tumors from colon cancer patients. Cancer Lett 115:39-46
18. Akehi S, Murao S, Ueda N, Okujima M, Magaribuchi T, Saheki S et al (1996) Immunohistochemical detection of truncated APC protein in sporadic human colorectal adenomas and adenocarcinomas. Virchows Arch 429:21-26
19. Grady WM, Markowitz SD (2002) Genetic and epigenetic alterations in colon cancer. Annu Rev Genomics Hum Genet 3:101-128
20. Miyakura Y, Sugano K, Fukayama N, Konishi F, Nagai H (2002) Concurrent mutations of K-ras oncogene at codons 12 and 22 in colon cancer. Jpn J Clin Oncol 32:219-221
21. Pajkos G, Kiss I, Sandor J, Ember I, Kishazi P (2000) The prognostic value of the presence of mutations at the codons 12, 13 and 61 of K-ras oncogene in colorectal cancer. Anticancer Res 20:1695-1701
22. Barbera VM, Martin M, Marinoso L, Munne A, Carrato A, Real FX et al (2000) The 18q21 region in colorectal and pancreatic cancer: Independent loss and DCC and DPC4 expression. Biochim Biophys Acta 1502:283-296
23. Hedrick L, Cho KR, Fearon ER, Wu TC, Kinzler KW, Vogelstein B (1994) The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev 8:1174-1183
24. Terdiman JP, Aust DE, Chang CG, Willenbucher RF, Baretton GB, Waldman FM (2002) High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer. Cancer Genet Cytogenet 136:129-137
25. Itzkowitz S (2003) Colon carcinogenesis in inflammatory bowel disease. J Clin Gastroenterol 36(5 Suppl):S70-S74
26. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
27. Ahomadegbe JC, Barrois M, Fogel S, Ml Le Bihan, Douc-Rasy S, Duvillard P et al (1995) High incidence of TP53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome frequent protein overexpression in normal epithelium and in early non-invasive lesions. Oncogene 10:1217-1227
28. Kapitanovic S, Cacev T, Spaventi R, Pavelic K (2001) Submerged gel electrophoresis on spreadex gels - a new method for APC gene mutation detection. J Mol Med 79:333-337
29. Abdel-Rahman SZ, el-Zein RA, Anwar WA, Au WW (1996) A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 107:229-233
30. Lang SM, Stratakis DF, Heinzlmann M, Heldwein W, Wiebecke B, Loeschke K (1999) Molecular screening of patients with long standing extensive ulcerative colitis: Detection of p53 an Ki- ras mutations by single strand conformation polymorphism analysis and differential hybridization in colonic lavage fluid. Gut 44:822-825
31. Yin J, Harpaz N, Pong Y, Huang Y, Laurin J, Greenwald BD et al (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104:1633-1639
32. Tolbert DM, Noffsinger AE, Miller MA, DeVoe GW, Stemmermann GN, Macdonald JS et al (1999) p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status. Mod Pathol 12:54-60
33. Truelove SC, Witts LJ (1955) Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J 29:1041-1048
34. Harvey RF, Bradshaw MJ (1980) Measuring Crohn's disease activity. Lancet 1:1134-1135
35. Wardle TD, Hall L, Turnberg LA (1992) Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 33:1644-1651
36. Mihalatos M, Danielides I, Belogianni J, Harokopos E, Papadopoulou E, Kalimanis G et al (2003) Novel mutations of the APC gene in Greek familial adenomatous polyposis patients. Cancer Genet Cytogenet 141:65-70
37. Redston MS, Papadopoulos N, Caldas C, Kinzler KW, Kern SE (1995) Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 108:383-392
38. Bodmer W (1999) Familial adenomatous polyposis (FAP) and its gene, APC. Cytogenet Cell Genet 86:99-104
39. Aust DE, Terdiman JP, Willenbucher RF, Chang CG, Molinaro-Clark A, Baretton GB et al (2002) The APC/beta-catenin pathway in ulcerative colitis-related colorectal carcinomas: A mutational analysis. Cancer 94:1421-1427
40. Umetani N, Sasaki S, Masaki T, Watanabe T, Matsuda K, Muto T (2000) Involvement of APC and K-ras mutation in non-polyposis colorectal tumorigenesis. Br J Cancer 82:9-15
41. Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, Jiang HY et al (1995) Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 15(55):2035-2038
42. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC et al (1994) Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369-378
43. Noffsinger AE, Belli JM, Miller MA, Fenoglio-Preiser CM (2001) A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene. Histopathology 39:482-492
44. Maia L, Dinis J, Cravo M, Claro I, Baltazar C, Fonseca I et al (2005) Who takes the lead in the development of ulcerative colitis-associated colorectal cancers: Mutator, suppressor, or methylator pathway? Cancer Genet Cytogenet 62:68-73
45. Heinzlmann M, Lang SM, Neynaber S, Reinshagen M, Emmrich J, Stratakis DF et al (2002) Screening for p53 and K-ras mutations in whole-gut lavage in chronic inflammatory bowel disease. Eur J Gastroenterol Hepatol 14:1061-1066
46. Rashid A, Hamilton SR (1997) Genetic alterations in sporadic and Crohn's-associated adenocarcinomas of the small intestine. Gastroenterology 113:127-135